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THE MAMMARY TUMOR AGENT AND ITS IMPLICA-
TION IN CANCER RESEARCH*
HOWARD B. ANDERVONT
With the recognition of the honor of presenting this lecture is
mingled the pleasure of having known and admired Dr. Allen, a
man of broad interests, who had the gift of stimulating younger men
with his enthusiasm. On first meeting him, I was struck by his
friendliness, the ease with which he could be approached, and his
generosity. This last is typified by the amount of time he gave me
in helpful suggestions on the occasion of my first appearance on a
program with many ofthe well-known men in clinical and laboratory
cancer work. In addition, it is an added pleasure to have the oppor-
tunity of discussing with you the problem of cancer, in which he
was keenly interested and to which he made a fundamental contribu-
tion. With this background, it would be relatively easy to speak on
almost any phase of cancer; but the subject was chosen because it
may be used to imbue these lectures with the individuality of Dr.
Allen, for his interests were not confined to a particular field of
science or to one aspect of the cancer problem. Therefore, it seems
fitting to examine the problem of mammary carcinoma in mice and
the mammary-tumor agent as they relate to the broader side of
cancer.
Cancer of the mammary gland in mice has been studied more
intensively than has any other tumor of experimental animals. It
attained this distinction because it is located externally, is easy to
detect, and occurs with exceptional frequency in a common and
cheaply maintained laboratory animal. Study of this tumor has
pioneered many advances in experimental cancer. It was one of the
first to be established as a malignant growth of lower animals at a
time when neoplasia was considered an exclusively human disease.
It was used to show the importance of hereditary factors in tumor
growth long before the production of inbred strains; and when
geneticists first established inbred strains of mice in cancer research,
susceptibility to this tumor was used as the basis of selection. It was
the first tumor used to reveal the relationship between hormonal
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stimulation and the occurrence of cancer in an experimental animal
and it was employed extensively in the earlier work on nutrition
in cancer.
Ittaught the importance oflong-term projects in cancer research.
This came about fortuitously enough, for, as has been mentioned
previously, the tumor of the mammary gland was the tumor
most generally used to attack any phase of the problem. To
begin with, investigators in the Imperial Cancer Research Fund
Laboratories and others devoted considerable time to prove that
breast tumors in mice, as well as other tumors, were malignant
growths and were similar to malignancies arising in man. Here was
laid a firm foundation upon which we continue to build. Then genet-
icists who had used the mouse as a convenient animal for much
experimental genetic work developed inbred strains especially
selected for high and low tumor incidence. Much of this was done
by workers who are or have been connected with the Roscoe B. Jack-
son Memorial Laboratory. Such work continues there and at widely
scattered places. Discovery of the milk agent' in mammary cancer
of mice and the development of a high gastric-cancer strain of mice"5
are two of the outstanding achievements emerging from this trend
of work.
Again, a third trend, developing concurrently and contributing
to the foundation of today's knowledge and accomplishments, was
the study of the relationship of hormones to mammary cancer in
mice, begun by investigators at the Washington University School
of Medicine, from which have stemmed fundamental observations
for many years. Among these was the demonstration by Allen1 of
the existence of an active ovarian hormone, which, followed by his
work on the biologic activities of the hormone, led to his interest in
the cancer problem.
Hence, we see that the discovery of the mammary-tumor agent
was preceded by years of thoughtful effort on the part of many
investigators working in different fields and interested in different
phases perhaps, but all concentrated on the study of one type of
neoplasm.
The discovery that mother's milk contains an agent responsible
for the occurrence of mammary cancer in mice was one of the most
important contributions to cancer research. How was this discovery
made? As early as 1918 it was noted11 that the incidence of mam-
mary tumors in hybrid mice was more often dependent upon the
tumor rate of their mothers thtan upon that of their fathers; but this
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observation could not be interpreted with confidence until the estab-
lishment of inbred strains of mice capable of satisfying the require-
ments of controlled genetic experiments. At least 20 generations of
brofher-to-sister matings are essential before a mouse strain is con-
sidered homozygous, and careful selection by geneticists produced
some strains in which virtually all breeding females developed breast
cancer and other strains in which the incidence was less than 1 per
cent. Reciprocal breeding between such inbred strains'4 revealed
that females born to the high-tumor-strain mothers developed mam-
mary cancer but those born to low-tumor-strain mothers remained
relatively free of such tumors. This phenomenon could not be
explained by any known genetic theory and was therefore thought
to be due to nongenetic influences. It was suggested'0 that this influ-
ence couldbe transmitted (1) -by way of the cyptoplasm of the ovum,
(2) during intra-uterine life, and (3) by way of the mother's milk.
By foster nursing females from high- and low-tumor strains, it
was soon found that mother's milk was responsi'ble. Mice born to
a high-tumor-strain mother and suckledbyalow-tumor-strain female
did not develop mammary cancer, whereas those born to a low-
tumor-strain -mother and suckled by a high-tumor-strain mouse
developed this type of tumor. Many similar experiments in differ-
ent parts of the world have proved that mother's milk contains an
agent WVhich is essential for the production of most breast tumors in
the inbred mouse. Investigations leading up to and revealing the
presence of the agent were carried out by geneticists, Vho called it
the extrachromosomal influence. It is also referred to as the mam-
mary-tumor inciter, the mammary-tumor influence or agent, the
milk influence, the milk agent, the milk factor, and the mouse mam-
mary-tumor virus.
This lecture will not be devoted to a detailed description of
the experiments performed to characterize the agent because this has
been done at frequent intervals4 8 A few of the more interesting
properties of the agent will be mentioned, and then we shall proceed
to some of its implications in cancer research.
The agent is filterable through Seitz or Berkefeld filters. It can
be sedimented by ultracentrifugation, remains active for at least 6
months after lyophilization, does not survive glycerolation for an
appreciable length of time, survives and may even become more
concentrated in the yolk sac of chicken eggs, survives desiccation at
room temperatures, and is not in the ether-soluble fraction of milk or
mammary tissue. It is destroyed in mouse milk heated to 610 C.
335YALE JOURNAL OF BIOLOGY AND MEDICINE
for 30 minutes and in tissue extracts heated to 56° for 30 minutes,
which indicates that the agent is destroyed by the heat of pasteuriza-
tion. When injected into rabbits, it elicits neutralizing antibodies
which are active in vitro and in vivo.
The appearance of any tumor is probably the result of the inter-
action of a number of influences, and breast cancers in mice are no
exception, for at least three factors are important in their production.
These are usually referred to as the genetic influence, the hormonal
influence, and the milk influence, but other environmental influences
are also involved.
The genetic influence determines the susceptibility of the mam-
mary tissue to the mammary tumor agent as well as the ability of the
mouse to propagate or transmit the agent. It may also control the
susceptibility of the mammary tissue to hormonal stimulation and
may modify the mechanism of hormonal stimuli.
Hormonescontrol the development ofthebreastandthusprovide
a tissue or substrate for the action of the agent and other influences,
for mammary tumors do not arise in mice in the absence of estrogenic
activity. It is possible that hormones exert some effect upon the
propagaition of the agent.
These influences, genetic and hormonal, are mentioned to empha-
size that the mammary tumor agent should not be regarded as the
cause ofbreast cancer in mice. All three factors are important, and in
certain instances it is impossible to state which is the most important.
For example, in one inbred mouse strain only 5 per cent of virgin
females develop mammary tumors while over 90 per cent of breed-
ing females do so. Since all are exposed to the same agent, it is clear
that their striking differences in tumor rates must be due to breeding
and in all probability to hormonal stimuli. Again, the agent disap-
pears or becomes ineffective after a few generations of appropriate
matings -of inbred mouse strains."3 Here the genetic influence pre-
dominates over the agent. Environmental factors, such as under-
feedingand overcrowding, also affect the genesis of mammary cancer
in mice. The mammary-tumor agent is no exception to other extrin-
sic disease-producing agents, for its effects are modified by genetic
and environmental factors.
This brings us to the first implication derived from the study of
this agent. In the past, the discovery that a transmissible agent was
responsible for the production of a given malignant tumor usually
occurred shortly after the tumor was transplanted into susceptible
animals, and it precipitated considerable discussion whether the
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growths were or were not true tumors. However, mammary can-
cers in mice were established as malignant growths long before the
agent was found. They grow progressively, invade surrounding
tissues, recur after incomplete removal, metastasize, and are trans-
plantable. A filterable agent is involved in the causation of this
tumor. If this view is not accepted, then the definition of a malig-
nant growth mustbe altered or it must be admittedthat such growths
cease to be malignant if an extrinsic agent is involved in their origin.
Another implication is derived from the fact that a filterable,
disease-producing agent is transferred in mother's milk. Are other
diseases of unknown etiology transmitted in this manner? Before
discovery of the agent, mammary cancer in the mouse was thought
to be controlled by genetic and hormonal influences. In fact, the
experiments which led to its discovery"4 were designed to evaluate
the genetic factors. We do not know whether similar agents are
responsible for breast cancers in other species, and thus far the evi-
dence indicates that the mammary-tumor agent is not involved in the
genesis of other tumors of mice. Further, mouse milk is not known
tocontain any other tumor-inciting agent; but there are experimental
results'2 indicating that mouse milk exerts some control over the
transmission of susceptibility to certain transplanted tumors, and this
influence is not the mammary-tumor agent. In the search for other
milk influences, investigators should not be prejudiced by the knowl-
edge that the mammary-tumor agent ispresent in mouse milk during
the entire period of lactation and is even widely distributed through-
out the body of the animal. It may be unwise to assume that this
is true ifother agents are conveyed in the milk of the mouse or other
species. The agent opens a new approach to the study of parental
influences in the transmission of disease, for the possibility that
chronic diseases maybe the results of the interaction of agents carried
in mother's milk and environmental factors offers a field for investi-
gation.
The latency of the agent presents other implications in the study
of cancer and other diseases. Despite the appearance of tumors long
after the administration of the agent, it could be assumed that the
agent infects the mammary tissue soon after it enters the body of the
mouse but that the appearance of a tumor must await the action of
hormonal or environmental stimuli. When thus considered, the
agent is comparable to the causative agent of tuberculosis, which can
maintain a focus of infection capable of producing the clinically
recognizable disease if environmental factors are favorable. Up to
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the present time, no immediate changes in the organism of the mouse
have been described following introduction of the agent, but there
is some evidence that the architecture *of the mammary gland is
altered. It could also be assumed that the agent increases slowly
and induces tumors when a critical amount is present.
If we define latency as the period elapsing between administra-
tion of the agent and the appearance of a tumor, then the agent has
an extremely long latent period. A susceptible newborn mouse need
remain with its mother for only a few hours after birth, and the
small amount of milk ingested during that time is sufficient to permit
a tumor to develop in middle or later life. When as little as 0.1 cc.
ofmilk is injected into youngmicesubcutaneouslyorintraperitoneally
or fed by means of a stomach tube, virtually all will develop tumors
months later, a fact that indicates that this amount of milk is far
above the smallest dose necessary. It is also known that tumor
development is not essential for transmission of the agent from
mother to offspring, in fact the agent is seldom transferred by way
of the milk in the presence of recognized tumors. In certain high-
tumor strains of mice if every mother were killed after she had
weaned her first litter, the agent could be carried from generation to
generation without any manifestation of disease. Mammary cancer
in the mouse may be looked upon as an excellent example of a latent
virus infection.
What can be inferred from the latency of the agent? First, it
is obvious that an event takes place in the first few hours of life
which leads to the appearance of cancer months later. This suggests
the possibility that other diseases, especially the chronic diseases, may
be caused by transmissible agents and have their roots far in the past.
Second, an epidemiologist who attempts to evaluate a mammary-
tumor agent in the milk of other species must know that only a small
amount of milk in early life is necessary to produce a tumor in mice.
Ingestion of milk suspected ofcontaining an agent must be ruled out
completely. An epidemiologist must also realize that the agent sur-
vives and is transmitted in the absence of recognized neoplasia, so
this could also be true for other diseases. The detection of agents
comparable to the mammary-tumor agent may demand the applica-
tion of experimental epidemiologic techniques.
Perhaps the most interesting implication drawn from the latency
of the agent is the realization of the danger df attempting to draw
lines of distinction between tumors on the basis of their etiologic
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agents. Filtration and ultracentrifugation experiments show that the
agent can be transmitted by cell-free material, and its tiransference
through many generations of mice implies propagation. Now there
are other tumors of experimental animals, which are also caused by
filterable agents and are often called virus-induced tumors. The
tendency has been to place these tumors in a special category by
describing certain common properties, among which is the short incu-
bation period between application of the agents and the occurrence
of tumors. Indeed, it has been emphasized that this short latent
period is one of the outstanding differences between these growths
and those induced with chemical carcinogens. While the mammary-
tumor agent possesses certain properties in common with the agents
of these virus-induced tumors, such as filterability and resistance to
heat, as well as tissue and species specificity, it differs remarkably in
its relatively long latent period, and in fact resembles the chemical
carcinogens. In other words, the agent exhibits some properties in
common with the agents of virus-induced tumors and some in com-
mon with the carcinogenic chemicals. It is a sort of hybirid. Should
we attempt to place cancers in separate groups according to their
etiology, or should we treat each tumor as a separate disease? Cer-
tainly the study of mammary cancers in mice teaches us to forego
generalizations, to consider each type of tumor as a disease entity,
and above all to keep an open mind regarding etiology.
The soundness of this approach is shown by the results achieved
in the control of breast cancer in the mouse. Appreciation of the
importance of hereditary factors led to the virtual elimination of the
disease in some mice by the process of inbreeding and selection. In
the highly susceptible inbred strains control was another story.
Here the disease was prevented by ovariectomy; but this method was
impractical because the ovaries had to be removed before the animals
reached the age of reproduction, and control of the disease by this
procedure would lead to the disappearance of the strain. Neverthe-
less, the individual could be spared by acknowledging the import-
ance of estrogenic stimulation. Finally, recognition of the mam-
mary-tumor agent as the etiologic agent of this disease contributed
to its prevention in the high-tumor strains by the simple expedient
of eliminating the agent from the milk. This was accomplished by
appropriate foster nursing of mice from susceptible strains before
they ingested any of their mother's milk. Breast cancer has not
occurred in many generations of descendants of these mice, although
they still retain their genetic susceptibility to the agent.
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The implications here are twofold: (1) Although discovery of
the agent added to the complexity of the problem of breast cancers
in mice, it also gave us a method of prevention; the more we learned
of this disease, the better became our opportunities for control. (2)
The prevention of a tumor was accomplished without the acquisition
of knowledge concerning the fundamental changes involved when
cells acquire malignant properties. This knowledge may be neces-
sary to prevent other cancers, but here is one tumor in a single
species where it was not essential. This may be a ray of hope to
those who hold that the prevention and cure of cancer may not
require a complete understanding of the differences between the
normal and the malignant cell.
Other properties of the agent could 'be used to present other
implications which it has in cancer research and other diseases, but it
may be of more interest to leave these and turn to some of the con-
tributions that we may expect from further studies of the agent.
One problem of much interest to cancer investigators is whether
a transmissible agent, such as the mammary-tumor agent, is essential
for the propagation of malignant cells or whether after initiating a
chain of events it can disappear or become inactive while the tumor
cells continue to multiply.
Those who suggest avirus theory of the origin of cancer maintain
that inability to detect a virus by known techniques does not prove
that one is not involved, and in support of this assertion they can
point to the study of breast cancer in the mouse. We know now
that the agent is present in tumors of high-cancer-strain mice and that
it can be detected by the injection of filtrates of these tumors into
susceptible mice. The techniques employed are similar to those
used to reveal the presence of agents in the virus-induced tumors
except the possibility that young animals should receive the filtrates
from the mouse cancers. But the mouse mammary-tumor agent was
not discovered by the administration of tumor filtrates. One reason
for the failure of this kind of experiment was probably caused by too
much dependence upon experience with the known virus-induced
tumors, for the inoculation of a filtrate prepared from one of them
usually produces a tumor at the site of administration in a short
period oftime. This is not the case with the mammary-tumor agent.
While the virus-induced tumors usually contain the virus, is it not
possible that we may again be too dependent upon previous experi-
ence if we assume that the mammary-tumor agent must be present
for the propagation of malignant cells? While there is no proof
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that malignant cells fail to multiply in the absence of tumor-produc-
ing viruses, and although it may not be possible to separate the virus
from the cells in othertumors, should we insist that this is true for all
tumors caused bytransmissible agents?
The mammary-tumor agent presents a new approach to the prob-
lem of the relationship of the etiologic agent to the propagation of
tumor cells. This is based upon the varyingdegrees of susceptibility
to the agent exhibited by different inbred strains of mice. Thus far
the agent has been found in the milk of all high-tumor strains of
inbred mice and in none of the well-known low-tumor strains.
When the agent was introduced by foster nursing into one low-tumor
strain, it transformed the strain into a high-tumor strain and the
strain has remained high-tumor for many generations; but when
introduced into another low-tumor strain, theagentdisappeared from
the milk or became inactive after one generation of inbreeding.2
Yet the agent will evoke tumors in the latter resistant strain if appro-
priate techniques are used. One experimental approach would,
therefore, consist of the transplantation of an agent-induced tumor
into other individuals of the resistant strain. If the presence of the
agent is necessary for the propagation of tumor cells, the tumor may
not survive manypassages. Ifthe tumor undergoes a series of trans-
plant generations, it can then The tested for the presence of the agent.
Should this test fail to detect the agent, the results would suggest
that the agent had disappeared from the tumor and the cells had
continued to multiply. Such findings would certainly stimulate dis-
cussion and further investigations.
In case this sounds too hypothetical, it is important to note
that the literature contains experimental observations suggesting the
disappearance of the agent from transplanted mammary carcinomas
of mice4 and, more important, statements to the effect that the agent
disappeared from the milk or became inactive6 in subsequent genera-
tions of a high-tumor strain of mice. Also, it has been shown16 that
growths produced in plants following inoculation of an organism will
continue after removal of the inciting agent.
There is another problem in which the mammary-tumor agent
may be used advantageously, namely, the problem concerning acti-
vation of alatent infection and the origin of viruses. Recently mam-
mary cancers were induced in some inbred mice and their hybrids
by subcutaneous injection or skin painting of a chemical carcinogen,
and some of these animals were known to be free of the mammary-
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tumor agent. Strangely enough, there is no record that any of these
tumors were tested for the presence of the agent although the results
of such tests would be of considerable interest. Detection of the
agent in these tumors would suggest that it was present in the ani-
mals as a latent infection or was produced in the animal. If the test
failed to reveal the presence of the agent, then the tumors may have
a different etiology than those in which the agent is involved.
There is no reason to assume that all spontaneous mammary
tumors in mice are caused by the agent. It is true that all the pres-
ent high-tumor strains possess the agent, but these strains were estab-
lished before the agent was found. The production of the inbred
strains demanded brother-to-sister matings and selection toward or
away from tumor development, and in all probability the selection
resulting in the present high- or low-tumor strains was toward sus-
ceptibility to or resistance to the agent. As stated previously, the
establishment of these strains was even necessary before the exist-
ence of the agent could be proved. It is of interest to speculate that
the geneticists not only selected toward susceptibility to the agent but
also may have selected 'toward a genetic constitution that permitted
the activation of a latent infection. This conjecture is open to experi-
mentation, for if mice develop spontaneous breast cancers that are
etiologically distinct from those caused by the agent, then it should
be possible to produce a high-breast-tumor strain that is free of the
agent.
There are some experimental observations reported which indi-
cate that the milk agent may be endogenous. One investigator7
freed high-tumor females of the agent and found that their descend-
ants for seven generations did not develop tumor; but one mouse
of the eighth genera'tion became cancerous, and her descendants for
four generations gave a high incidence of breast tumors. Others9
transferred fertilized ova from high-tumor-strain females into the
uteri of low-tumor-strain females; and when the mice from the
transferred ova were born, they were suckled by the low-tumor-
strain females. None of these mice developed tumor, but in the
first three generations of their descendants the incidence of breast
cancer was 11 per cent. A test for the presence of the agent in any
of these tumor-bearing mice was not recorded; but if the agent was
responsible for the tumors, it is important to ascertain how it entered
the animals. Since the agent is an extrinsic disease-producing one,
it is conceivable t(hat it may be transmitted by routes other than the
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mother's milk, but there is little evidence to support this idea. Mice
with or without the agent are kept in close contact in many labora-
tories, and no evidence of contagion has been recorded. Further-
more, when newborn mice were kept with their high-tumor-strain
mothers but were not permitted to obtain any of their mother's milk,
theydid not develop tumor.
Another approach to the problem of the endogenous origin of
the agent has been opened recently. Investigators in several labora-
tories found that when the offspring of certain matings between low-
tumor-strain females and high-tumor-strain males were subjected to
intensive hormonal stimulation they revealed a high incidence of
breast tumors. In one experiment,3 the milk of the low-tumor-strain
females was tested for the agenit by permitting them to suckle highly
susceptible mice. This test was essentially negative. Tumors arising
in the hybrids were also examined for the agent, and these tests also
proved negative. These results suggest that the agent was not impli-
cated in the origin of the tumors found in the hybrids.
These hybrids may be used in attempts to ascertain whether the
agent occurs endogenously in them, whether it is in the latent or
inlactive state in their mothers and is activated in the hybrids, or
whetiher the agent is not necessary for the tumors in the hybrids.
One method 'of attack could be as follows: The hybrids are bred
before and after they develop tumors, and 'their offspring are kept
to see whether they develop breast cancers. Should tumors appear
in those offspring born before and after the hybrids become cancer-
ous, it would suggest that the hybrids obtained the agent in early
life. This would indicate that the low-tumor-strain females har-
bored the agent without developing 'tumors or became infected
through contact with the high-tumor-strain male. Should tumors
occur only in those offspring born after the hybrids developed
tumors, it would indicate that the agent was produced in the tissues
of the hybrids or in their tumors. Should offspring or an occasional
one grow a tumor, it would suggest that the tumors appearing in
the hybrids were etiologically distinct from those induced with
the agent.
There are aspects of this kind of experiment which need not be
considered now. It is hoped that this brief outline demonstrates how
studies with the agent can be used in attempts to throw some light
on problems of general interest to those working with infectious
agents.
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Viewed as an infectious agent, the mammary-tumor agent has the
unique characteristics of a long period of incubation and the ease
with which it is detectable. In some respects, it is comparable to the
virus of herpes simplex in man. Both agents incite diseases that
usually arise spontaneously and are influenced by environmental
factors. Both diseases are relatively easy to transmit by reinoculation
of the individual in which they appear but difficult to transmit to
other individuals of the same species which possess a different
genetic constitution. However, the mammary-tumor agent does not
possess any characteristic distinctive from all other known infectious
agents.
It is not the purpose of this discussion to imply that all tumors
are caused by agents similar to the mouse mammary-tumor agent.
The discovery of this agent has, however, given added impetus to
a theory of cancer origin which only a few years ago had few friends
in cancer research. Now, there is hardly an investigator who will
not listen with interest. Finally, the study ofthe agent should instill
enthusiasm and teach the value of an open-minded approach to the
cancer problem. Since such enthusiasm and open-mindedness were
characteristic quali-ties of Dr. Allen, the subject chosen seems appro-
priate for the first Edgar Allen Memorial Lecture.
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